The 'Improvement of HF' initiative to increase awareness and improve the management of heart failure in Europe;'Improvement of HF': Un'iniziativa per aumentare l'informazione e migliorare la gestione dei pazienti con scompenso cardiaco in Europa

Giornale Italiano di Cardiologia

Volumn 29, Issue 12, 1999, Pages 1445-1451

  Gavazzi, Antonello ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Guidelines; Heart failure

Indexed keywords

AGING; ARTICLE; EDUCATION PROGRAM; EUROPE; HEALTH SURVEY; HEART FAILURE; PHYSICIAN; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; CONGESTIVE HEART FAILURE; HUMAN; INFORMATION SYSTEM; PROGRAM DEVELOPMENT;

EUROPE; HEART FAILURE, CONGESTIVE; HUMANS; INFORMATION SYSTEMS; PROGRAM DEVELOPMENT;

EID: 0033233439     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. TAVAZZI L: Epidemiological burden of heart failure. Heart 1998; 79 (Suppl 2): S6-S9.
2. TASK FORCE OF HEART FAILURE OF THE EUROPEAN SOCIETY OF CARDIOLOGY: Guidelines for the diagnosis of heart failure. Eur Heart J 1995; 16: 741-751.
3. TASK FORCE OF THE WORKING GROUP ON HEART FAILURE OF THE EUROPEAN SOCIETY OF CARDIOLOGY: The treament of heart failure. Eur Heart J 1997; 18: 736-753.
4. KONSTAM MA, DRACUP K, BAKER DW, ET AL: Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. Clinical practice guideline No. 11. AHCPR Publication No. 94-0612, Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, June 1994.
5. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 1995; 92: 2764-2784.
6. GAVAZZI A, BARSOTTI A, BIANCHI A, ET AL: Linee guida sullo scompenso cardiaco. In: Linee guida cliniche, Associazione Nazionale Medici Cardiologi Ospedalieri e Società Italiana di Cardiologia in collaborazione con Associazione Nazionale Cardiologi Extraospedalieri e Società Italiana di Cardiologia Pediatrica. Padova, Piccin Nuova Libraria S.p.A., 1998; 169-247.
7. COHN JN: The management of chronic heart failure. N Engl J Med 1996; 335: 490-498.
8. DIGITALIS INVESTIGATION GROUP: The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-533.
9. FRANCIS GS, COHN JN, JOHNSON G, ET AL: Plasma norepinephrine, plasma renin activity and congestive heart failure: relations to survival and the effects of therapy in V-HeFTII follow-up. Circulation 1993; 87 (Suppl VI): VI-40 VI-48.
10. KALON K, HO L, PINSKY JL, ET AL: The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 1993; 22 (Suppl A): 6A-13A.
11. LAMAS GA, PFEFFER MA, HAMM P, WERTHEIMER J, ROULEAU JL, BRAUNWALD E: Do results of randomized clnical trials of cardiovascular drugs influence medical practice? The SAVE investigators. N Engl J Med 1992; 327: 241-247.
12. CLELAND JGF, SWEDBERG K, POOLE-WILSON PA: Successes and failures of current treatment of heart failure. Lancet 1998; 352: 19-28.
13. CLELAND JGF, FREEMANTLE N, MCGOWAN J, CLARK A: The evidence for beta-blockers equals or surpassess that for ACE inhibitors in heart failure. Br Med J 1999; 318: 824-825.
14. YOUNG JB, GHEORGHIADE M, URETSKY BF, PATTERSON JH, ADAMS KF: Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. J Am Coll Cardiol 1998; 32: 686-692.